Chapter 1 Resveratrol: A Polyphenol for All Seasons |
|
1 | (16) |
|
Shishir Shishodia and Bharat B. Aggarwal |
|
|
|
|
2 | (1) |
|
|
2 | (8) |
|
Salient Features of Resveratrol |
|
|
4 | (1) |
|
Resveratrol as a COX-2 Inhibitor |
|
|
4 | (4) |
|
Chemosensitization by Resveratrol |
|
|
8 | (1) |
|
Radiosensitization by Resveratrol |
|
|
9 | (1) |
|
Resveratrol as Antiviral Agent |
|
|
9 | (1) |
|
Bioavailability of Resveratrol |
|
|
10 | (1) |
|
Clinical Trials with Resveratrol |
|
|
10 | (2) |
|
|
12 | (1) |
|
|
12 | (1) |
|
|
13 | (4) |
Chapter 2 Sources and Chemistry of Resveratrol |
|
17 | (16) |
|
Navindra P. Seeram, Vishal V. Kulkami, and Subhash Padhye |
|
|
|
|
17 | (1) |
|
|
18 | (5) |
|
|
23 | (1) |
|
Chemical Analyses of Resveratrol |
|
|
24 | (1) |
|
|
24 | (1) |
|
Theoretical and SAR Studies of Resveratrol |
|
|
25 | (1) |
|
|
26 | (1) |
|
|
27 | (6) |
Chapter 3 Resveratrol as an Antioxidant |
|
33 | (24) |
|
Catalina Alarcón de la Lastra, Isabel Villegas, and Antonio Ramón Martin |
|
|
|
|
33 | (3) |
|
Resveratrol as Free Radical Scavenger and Antioxidant |
|
|
36 | (2) |
|
Effects of Resveratrol on Lipid Peroxidation |
|
|
38 | (2) |
|
Effects of Resveratrol on Intracellular Redox State |
|
|
40 | (1) |
|
Antioxidant Activity of Resveratrol and Cardioprotection |
|
|
41 | (2) |
|
Effects of Resveratrol on Nitrogen Reactive Species Generation |
|
|
43 | (1) |
|
Antioxidant Activity of Resveratrol and Hepatoprotection |
|
|
44 | (1) |
|
Antioxidant Activity of Resveratrol and Neuroprotection |
|
|
44 | (3) |
|
Antioxidant Activity of Resveratrol and Carcinogenesis |
|
|
47 | (3) |
|
|
50 | (7) |
Chapter 4 Resveratrol as an Antiproliferative Agent for Cancer |
|
57 | (28) |
|
Paola Signorelli and Riccardo Ghidoni |
|
|
|
|
58 | (1) |
|
Antiproliferative Effects in Various Types of Cancer |
|
|
58 | (13) |
|
|
58 | (3) |
|
Resveratrol as a Phytoestrogen |
|
|
59 | (1) |
|
|
59 | (1) |
|
|
60 | (1) |
|
|
61 | (1) |
|
Resveratrol as a Phytoestrogen |
|
|
61 | (1) |
|
|
61 | (1) |
|
Colon and Digestive Tract Cancers |
|
|
62 | (1) |
|
|
62 | (1) |
|
|
63 | (1) |
|
|
63 | (1) |
|
|
64 | (1) |
|
|
64 | (1) |
|
|
64 | (2) |
|
|
65 | (1) |
|
|
65 | (1) |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
66 | (1) |
|
Cancer of the Brain and Other Nervous Tissues |
|
|
66 | (1) |
|
|
67 | (1) |
|
|
67 | (1) |
|
Cancers of the Female Genital Apparatus |
|
|
67 | (2) |
|
Resveratrol as a Phytoestrogen |
|
|
68 | (1) |
|
|
68 | (1) |
|
|
69 | (1) |
|
|
69 | (1) |
|
|
70 | (1) |
|
|
70 | (15) |
|
|
70 | (1) |
|
|
71 | (1) |
|
|
71 | (1) |
|
Conclusions and Perspectives |
|
|
71 | (7) |
|
|
78 | (7) |
Chapter 5 Mechanism of Apoptosis by Resveratrol |
|
85 | (20) |
|
Shazib Pervaiz and Andrea Lisa Holme |
|
|
|
Introduction to Apoptosis |
|
|
85 | (3) |
|
Apoptosis in Cancer Therapy |
|
|
87 | (1) |
|
Resveratrol as a Mediator of Cell Death |
|
|
88 | (5) |
|
Death Receptor-Mediated Apoptosis |
|
|
88 | (1) |
|
Mitochondria-Mediated Apoptosis |
|
|
89 | (1) |
|
Apoptosis Mediated by Nuclear Factors |
|
|
90 | (2) |
|
Resveratrol Affects Nuclear Receptors to Induce Apoptosis |
|
|
92 | (1) |
|
Resveratrol: A Pluripotent Phytoalexin |
|
|
93 | (5) |
|
Resveratrol Sensitization to Drug-Induced Apoptosis |
|
|
94 | (1) |
|
Clinical Relevance: A Conundrum |
|
|
95 | (3) |
|
|
98 | (1) |
|
|
98 | (7) |
Chapter 6 Resveratrol as Inhibitor of Cell Survival Signal Transduction |
|
105 | (14) |
|
Simone Fulda and Klaus-Michael Debatin |
|
|
|
|
106 | (1) |
|
|
106 | (1) |
|
Signal Transduction in Cell Death and Survival |
|
|
107 | (2) |
|
|
107 | (1) |
|
Nonapoptotic Forms of Cell Death |
|
|
107 | (1) |
|
Inhibitor of Apoptosis Proteins (IAPs) |
|
|
108 | (1) |
|
|
108 | (1) |
|
|
109 | (1) |
|
Resveratrol as Inhibitor of Cell Survival Signaling |
|
|
109 | (4) |
|
Inhibition of Antiapoptotic Pathways |
|
|
109 | (2) |
|
Inhibition of PI3K/AKT or MAPK Pathway |
|
|
111 | (1) |
|
Inhibition of Protein Kinase C (PKC) Superfamily |
|
|
112 | (1) |
|
Inhibition of NF-kappaB Pathway |
|
|
112 | (1) |
|
|
113 | (1) |
|
|
113 | (6) |
Chapter 7 Resveratrol as Inhibitor of Cell Cycle Progression |
|
119 | (14) |
|
|
|
|
120 | (1) |
|
Chemical Structures of Resveratrol and Its Derivatives |
|
|
121 | (1) |
|
Cancer Chemopreventive Effects of Resveratrol |
|
|
122 | (1) |
|
Apoptotic Effects of Resveratrol |
|
|
123 | (1) |
|
Inhibition of Cell Cycle Progression |
|
|
124 | (3) |
|
Effects of Resveratrol on the G0/G1 Transition in Human Lymphocytes |
|
|
124 | (1) |
|
Effects of Resveratrol on S-Phase Arrest in Prostate Carcinoma LNCaP Cells |
|
|
125 | (1) |
|
Effects of Resveratrol on S/G2 Phase Transition in Human Colonic Adenocarcinoma Caco-2 Cells |
|
|
125 | (1) |
|
Effects of Resveratrol on G2/M Arrest in Colon Carcinoma HT29 Cells |
|
|
126 | (1) |
|
Some Resveratrol Derivatives with Unique Biological Activity |
|
|
127 | (2) |
|
Piceatannol (Trans-3,3',4',5-tetrahydroxystilbene) |
|
|
127 | (1) |
|
Trans-3,3',4',5,5'-pentahydroxystilbene |
|
|
127 | (1) |
|
Trans-3,4,4',5-tetramethoxystilbene (DMU-212) |
|
|
128 | (1) |
|
Vaticanol C (A Resveratrol Oligomer) |
|
|
128 | (1) |
|
|
129 | (1) |
|
|
129 | (4) |
Chapter 8 Molecular Targets of Resveratrol: Implications to Health and Disease Prevention |
|
133 | (16) |
|
Catherine A. O'Brian and Feng Chu |
|
|
|
Molecular Targets of Resveratrol: Forestalling Senescence and Preventive Intervention against Cardiovascular, Metabolic, and Neurodegenerative Diseases |
|
|
133 | (3) |
|
Molecular Targets of Resveratrol: Cancer Prevention and Therapy |
|
|
136 | (7) |
|
Other Molecular Targets of Resveratrol |
|
|
143 | (1) |
|
|
143 | (1) |
|
|
144 | (5) |
Chapter 9 Resveratrol as an Angiogenesis Inhibitor |
|
149 | (18) |
|
Ebba Bråkenhielm, Renhai Cao, and Yihai Cao |
|
|
|
|
149 | (1) |
|
Antiangiogenic Activity of Resveratrol |
|
|
150 | (1) |
|
Antiangiogenic Mechanisms |
|
|
151 | (8) |
|
Inhibition of Signaling Pathways of Angiogenesis |
|
|
151 | (1) |
|
Effects on Fibrinolysis and Extracellular Proteases as a Potential Antiangiogenic Mechanism |
|
|
152 | (2) |
|
Stimulation of eNOS and Its Role in Regulation of Angiogenesis |
|
|
154 | (1) |
|
Inhibition of Cellular Adhesion Molecules |
|
|
154 | (2) |
|
Inhibition of COX Enzymes and Inflammatory Pathways in Angiogenesis |
|
|
156 | (1) |
|
Regulation of Transcription Factors and Nuclear Enzymes |
|
|
156 | (2) |
|
Inhibition of Cell Cycle and Induction of Apoptosis |
|
|
158 | (1) |
|
|
159 | (1) |
|
|
159 | (8) |
Chapter 10 Resveratrol Modulation of Gene Expression: The Role of Transcription Factors |
|
167 | (26) |
|
Fulvio Della Ragione, Valeria Cucciolla, Adriana Borriello, and Vincenzo Zappia |
|
|
|
|
168 | (1) |
|
Resveratrol and the Modulation of Inflammatory Response |
|
|
168 | (4) |
|
|
169 | (1) |
|
|
170 | (2) |
|
Resveratrol and Intracellular Receptors |
|
|
172 | (2) |
|
Resveratrol and the Androgen Receptor |
|
|
172 | (1) |
|
Resveratrol and the Estrogen Receptor |
|
|
173 | (1) |
|
Resveratrol and Aryl Hydrocarbon Receptors |
|
|
173 | (1) |
|
|
174 | (3) |
|
Resveratrol and Egr 1 Activation |
|
|
177 | (1) |
|
Protein Deacetylase Sirtuins: New Effectors of Resveratrol Activities |
|
|
178 | (4) |
|
Sirtuin Functions and Interactions |
|
|
178 | (3) |
|
Mechanistic Basis of Resveratrol Activatory Function |
|
|
181 | (1) |
|
Resveratrol and SIRT1: Effects on Transcription Factor Activity |
|
|
181 | (1) |
|
Conclusions and Perspectives |
|
|
182 | (1) |
|
|
183 | (1) |
|
|
183 | (10) |
Chapter 11 Modulation of Gene Expression by Resveratrol |
|
193 | (22) |
|
Bhagavathi A. Narayanan and Narayanan K. Narayanan |
|
|
|
|
193 | (1) |
|
Resveratrol and Molecular Targets |
|
|
194 | (1) |
|
Genomic Profiling of Resveratrol-Modulated Genes against Prostate Cancer |
|
|
195 | (4) |
|
Resveratrol-Modified Transmembrane Proteins, Transglutaminases, and Transcription Factors |
|
|
199 | (1) |
|
Effect of Resveratrol on Growth Factors and Hormones |
|
|
200 | (1) |
|
Resveratrol-Induced p53-Mediated Molecular Targets |
|
|
200 | (2) |
|
Resveratrol Modulates DNA Methylation: Insight from DNA Microarray Analysis |
|
|
202 | (1) |
|
Effect of Resveratrol on Methylation of p300 CpG Sites |
|
|
203 | (1) |
|
Resveratrol-Modulated Proteins |
|
|
203 | (1) |
|
Modulation of Phosphoglycerate Mutase B by Resveratrol |
|
|
204 | (4) |
|
|
208 | (1) |
|
|
208 | (1) |
|
|
208 | (7) |
Chapter 12 Resveratrol and Prostaglandin Biosynthesis |
|
215 | (18) |
|
Lawrence M. Szewczuk and Trevor M. Penning |
|
|
|
|
216 | (2) |
|
|
216 | (1) |
|
Prostaglandin Biosynthesis |
|
|
217 | (1) |
|
Catalytic Mechanism of COX |
|
|
217 | (1) |
|
COX Isozymes as Drug Targets |
|
|
218 | (3) |
|
COX-1 as a Target for Cardioprotective (Antiplatelet) Agents |
|
|
218 | (1) |
|
COX-2 as a Target for Antiinflammatory Agents |
|
|
219 | (1) |
|
COX-2 as a Target for Cancer Chemotherapeutic Agents |
|
|
220 | (1) |
|
Direct Effects of Resveratrol on COX Catalysis |
|
|
221 | (6) |
|
Early Findings 221 Resveratrol as a Mechanism-Based Inactivator of the Peroxidase Activity of COX-1 |
|
|
221 | (3) |
|
Structure—Activity Relationships (SARs) with Resveratrol Analogs |
|
|
224 | (2) |
|
[³H]-Resveratrol is Not Covalently Incorporated into COX-1 |
|
|
226 | (1) |
|
Trapping Resveratrol Radicals as Viniferins |
|
|
227 | (1) |
|
Effects of Resveratrol on COX-2 Expression |
|
|
227 | (2) |
|
Pharmacokinetics and Efficacy of Resveratrol (and Other m-Hydroquinones) |
|
|
229 | (1) |
|
|
229 | (1) |
|
|
230 | (3) |
Chapter 13 Resveratrol as an Inhibitor of Carcinogenesis |
|
233 | (152) |
|
|
|
|
234 | (1) |
|
Overview of Cancer Chemoprevention Trials Involving Phytochemicals |
|
|
235 | (1) |
|
Discovery and Characterization of Natural Product Inhibitors of Carcinogenesis |
|
|
236 | (1) |
|
Potential Cancer Chemopreventive Agents from Plants |
|
|
237 | (3) |
|
Phenomenon of Resveratrol |
|
|
240 | (2) |
|
In Vitro Studies Conducted with Resveratrol |
|
|
242 | (1) |
|
Cell Culture Studies Conducted with Resveratrol |
|
|
243 | (94) |
|
In Vivo Studies Conducted with Resveratrol |
|
|
337 | (24) |
|
|
361 | (2) |
|
|
363 | (1) |
|
|
363 | (22) |
Chapter 14 Resveratrol as an Antitumor Agent In Vivo |
|
385 | (14) |
|
|
|
|
385 | (1) |
|
Antitumor Effects and Antitumor Mechanisms In Vivo |
|
|
386 | (7) |
|
|
386 | (1) |
|
|
387 | (1) |
|
|
388 | (1) |
|
|
389 | (1) |
|
|
390 | (1) |
|
Colorectal and Intestinal Cancers |
|
|
391 | (1) |
|
|
392 | (1) |
|
Limitations in the Use of Resveratrol as an Antitumor Agent In Vivo |
|
|
393 | (1) |
|
|
394 | (1) |
|
|
395 | (4) |
Chapter 15 Resveratrol as a Sensitizer to Apoptosis-Inducing Stimuli |
|
399 | (24) |
|
Ali R. Jazirehi and Benjamin Bonavida |
|
|
|
|
399 | (1) |
|
Apoptosis and Resistance to Apoptosis |
|
|
400 | (3) |
|
|
400 | (2) |
|
|
402 | (1) |
|
|
403 | (1) |
|
Anticancer Therapeutic Effects of RSV and RSV Analogs |
|
|
404 | (4) |
|
Anticancer Therapeutic Effects of RSV |
|
|
404 | (2) |
|
|
406 | (2) |
|
|
408 | (1) |
|
Sensitizing Activities of RSV |
|
|
408 | (5) |
|
|
408 | (2) |
|
|
410 | (3) |
|
In Vivo Application of RSV |
|
|
413 | (1) |
|
|
413 | (3) |
|
|
416 | (1) |
|
|
416 | (7) |
Chapter 16 Resveratrol as a Radio-Protective Agent |
|
423 | (16) |
|
Yogeshwer Shukla, Shannon Reagan-Shaw, and Nihal Ahmad |
|
|
|
|
424 | (1) |
|
Solar UV Radiation and Skin Damages |
|
|
425 | (1) |
|
Antioxidants in Chemoprevention of Skin Cancer and Other Skin Damages |
|
|
426 | (1) |
|
Resveratrol: A Strong Chemopreventive Agent |
|
|
427 | (1) |
|
Effects of Resveratrol on Short-Term UVB Damages in Mouse Skin |
|
|
427 | (2) |
|
Effects of Resveratrol on Multiple UVB Exposure-Mediated Damages in Mouse Skin |
|
|
429 | (3) |
|
Effects of Resveratrol on UVB Exposure-Mediated Damages in Skin Keratinocytes In Vitro |
|
|
432 | (1) |
|
Resveratrol: An Enhancer of Therapeutic Response of Ionizing Radiation against Cancer Cells In Vitro |
|
|
433 | (1) |
|
|
434 | (1) |
|
|
435 | (4) |
Chapter 17 Resveratrol as a Phytoestrogen |
|
439 | (26) |
|
Barry D. Gehm and Anait S. Levenson |
|
|
|
|
439 | (2) |
|
Resveratrol as a Phytoestrogen |
|
|
441 | (15) |
|
Resveratrol and ER Isoforms |
|
|
441 | (1) |
|
Resveratrol's Estrogenic and Antiestrogenic Effects |
|
|
442 | (24) |
|
|
442 | (1) |
|
|
442 | (1) |
|
Endogenous Gene Expression |
|
|
446 | (1) |
|
Gene Expression Profiling |
|
|
447 | (1) |
|
Cultured Cell Proliferation |
|
|
450 | (1) |
|
Resveratrol: Agonist, Antagonist, or Superagonist? |
|
|
454 | (1) |
|
|
454 | (2) |
|
Resveratrol and Breast Cancer |
|
|
456 | (1) |
|
Are Resveratrol's ER-Mediated Actions Physiologically Relevant? |
|
|
457 | (1) |
|
|
458 | (1) |
|
|
459 | (1) |
|
|
459 | (6) |
Chapter 18 Resveratrol as an Antibacterial Agent |
|
465 | (10) |
|
|
|
|
465 | (1) |
|
Cardiovascular and Respiratory Bacteria |
|
|
466 | (2) |
|
|
466 | (2) |
|
Gastrointestinal Bacteria |
|
|
468 | (1) |
|
|
468 | (1) |
|
|
469 | (1) |
|
Thermo acid ophilic Bacteria |
|
|
470 | (1) |
|
Aticyclobacillus Acidoterrestris |
|
|
470 | (1) |
|
|
470 | (1) |
|
|
470 | (1) |
|
|
470 | (2) |
|
|
472 | (3) |
Chapter 19 Resveratrol as an Antifungal Agent |
|
475 | (24) |
|
Marielle Adrian and Philippe Jeandet |
|
|
|
|
475 | (2) |
|
Importance of Resveratrol in the Plant Kingdom |
|
|
475 | (1) |
|
Exciting Potential of This Fascinating Compound in Phytopathology |
|
|
476 | (1) |
|
|
477 | (4) |
|
|
477 | (2) |
|
|
479 | (1) |
|
|
480 | (1) |
|
|
481 | (5) |
|
|
482 | (2) |
|
Correlations between Phytoalexin Production and Disease Resistance |
|
|
484 | (1) |
|
|
485 | (1) |
|
|
486 | (2) |
|
|
488 | (1) |
|
|
488 | (11) |
Chapter 20 Protective Effects of Resveratrol in Age-Related Neurodegenerative Diseases and Gene Regulatory Action |
|
499 | (20) |
|
Sofiyan Saleem, Abdullah Shafique Ahmad, and Sylvain Doré |
|
|
|
|
499 | (4) |
|
|
503 | (2) |
|
|
505 | (2) |
|
|
507 | (1) |
|
|
507 | (1) |
|
|
508 | (1) |
|
|
508 | (1) |
|
|
509 | (1) |
|
|
509 | (10) |
Chapter 21 Protective Effects of Resveratrol against Ischemia-Reperfusion |
|
519 | (20) |
|
|
|
|
519 | (1) |
|
|
520 | (3) |
|
Resveratrol: A Grape-Derived Natural Antioxidant |
|
|
520 | (1) |
|
Resveratrol: A Phytoestrogen |
|
|
521 | (1) |
|
Resveratrol: Effective against a Variety of Degenerative Diseases |
|
|
522 | (1) |
|
Resveratrol and the Heart |
|
|
523 | (2) |
|
Preconditioning with Resveratrol |
|
|
525 | (5) |
|
Myocardial Protection with Preconditioning |
|
|
525 | (2) |
|
Pharmacological Preconditioning with Resveratrol |
|
|
527 | (3) |
|
|
530 | (1) |
|
|
530 | (1) |
|
|
530 | (9) |
Chapter 22 Resveratrol as Cardioprotective Agent: Evidence from Bench and Bedside |
|
539 | (18) |
|
Sukesh Burjonroppa and Ken Fujise |
|
|
|
|
540 | (1) |
|
Epidemiological Evidence to Support Resveratrol as a Cardioprotective Agent |
|
|
541 | (3) |
|
Red Wine as a Cardioprotective Agent: French Paradox |
|
|
541 | (2) |
|
Resveratrol as a Major Bioactive Agent in Red Wine |
|
|
543 | (1) |
|
Evidence in Clinical Trials to Support Resveratrol as a Cardioprotective Agent |
|
|
543 | (1) |
|
Animal Studies to Support Resveratrol as a Cardioprotective Agent |
|
|
544 | (3) |
|
Resveratrol Inhibits Neointimal Hyperplasia after Vascular Injury |
|
|
544 | (1) |
|
Resveratrol Inhibits Platelet Activation and Aggregation |
|
|
544 | (2) |
|
Resveratrol Dilates Arteries through Nitric Oxide-Mediated Pathways |
|
|
546 | (1) |
|
Resveratrol and Atherosclerosis |
|
|
546 | (1) |
|
Bench Research to Support Resveratrol as a Cardioprotective Agent |
|
|
547 | (3) |
|
Resveratrol Is an Antiendothelin Agent in Vascular Cells |
|
|
547 | (1) |
|
Resveratrol Is a Tissue Factor Inhibitor in Vascular Cells |
|
|
547 | (1) |
|
Resveratrol Is an Estrogen Receptor Agonist in Vascular Cells |
|
|
548 | (1) |
|
Resveratrol Upregulates and Activates p53 Tumor Suppressor Protein in Vascular Cells |
|
|
548 | (2) |
|
|
550 | (1) |
|
|
550 | (1) |
|
|
550 | (7) |
Chapter 23 Immunomodulation by Resveratrol |
|
557 | (20) |
|
Subhash C. Gautam, Xiaohua Gao, and Scott A. Dulchaysky |
|
|
|
|
557 | (2) |
|
Immunomodulation by Resveratrol |
|
|
559 | (1) |
|
Effect on Inflammatory Processes |
|
|
559 | (2) |
|
Modulation of Cell-Mediated Immunity by Resveratrol |
|
|
561 | (10) |
|
|
561 | (1) |
|
Effect on Antigen Presenting Cells |
|
|
562 | (1) |
|
Effect on T Cell Proliferation |
|
|
563 | (2) |
|
Effect on Cell-Mediated Cytotoxicity |
|
|
565 | (3) |
|
Effect on Production of Cytokines |
|
|
568 | (2) |
|
Effect on NF-kappaB Activation |
|
|
570 | (1) |
|
|
571 | (1) |
|
|
571 | (6) |
Chapter 24 Biological Effects of Cis- Versus Trans-Resveratrol |
|
577 | (24) |
|
|
|
|
577 | (2) |
|
Vasorelaxant Effects of t-RESV in Rat Aorta |
|
|
579 | (9) |
|
|
579 | (1) |
|
L-Arginine—NO-cGMP Pathway |
|
|
580 | (8) |
|
Does t-RESV Affect Synthesis/Release of NO from Endothelial Cells? |
|
|
582 | (1) |
|
Does t-RESV Affect Inactivation of NO.? |
|
|
583 | (3) |
|
Implications of the Increased NO. Levels Induced by t-RESV |
|
|
586 | (2) |
|
Vasorelaxant and Other Biological Effects of c-RESV |
|
|
588 | (4) |
|
Vasorelaxant Effects of c-RESV in the Rat Aorta |
|
|
588 | (2) |
|
Other Biological Effects of c-RESV |
|
|
590 | (2) |
|
|
592 | (1) |
|
|
593 | (1) |
|
|
594 | (7) |
Chapter 25 Resveratrol as an Antiinflammatory Agent |
|
601 | (18) |
|
Young-Joon Surh and Joydeb Kumar Kundu |
|
|
|
|
601 | (1) |
|
Inflammation as a Predisposing Factor for Various Human Diseases |
|
|
602 | (2) |
|
Resveratrol: A Natural Antiinflammatory Agent |
|
|
604 | (1) |
|
Molecular Mechanisms of the Antiinflammatory Activity of Resveratrol |
|
|
605 | (7) |
|
Inhibition of iNOS and COX-2 by Resveratrol |
|
|
605 | (5) |
|
Modulation of Transcription Factors Regulating Proinflammatory Genes |
|
|
610 | (2) |
|
Effects on the Activation of NF-kappaB |
|
|
610 | (1) |
|
Effects on the Activation of AP-1 |
|
|
611 | (1) |
|
Effects on the Intracellular Upstream Kinases |
|
|
612 | (1) |
|
|
612 | (1) |
|
|
613 | (1) |
|
|
613 | (6) |
Chapter 26 Neuroprotective Effects of Resveratrol |
|
619 | (12) |
|
Ying-Shan Han, Stéphane Bastianetto, and Rémi Quirion |
|
|
|
|
619 | (1) |
|
Neuroprotective Effects of Resveratrol and Its Analogs |
|
|
620 | (4) |
|
In Vitro and Animal Studies |
|
|
620 | (4) |
|
Structure–Activity Relationships of Resveratrol |
|
|
624 | (1) |
|
Potential Mechanisms of Neuroprotective Actions of Resveratrol |
|
|
624 | (2) |
|
Antioxidant/Metal-Chelating Activity |
|
|
624 | (1) |
|
Effects on Intracellular Signaling Pathways |
|
|
625 | (1) |
|
Effects on Transcription Factors and Gene Expression |
|
|
626 | (1) |
|
Conclusion and Future Directions |
|
|
626 | (1) |
|
|
627 | (4) |
Chapter 27 Pharmacokinetics and Metabolism of Resveratrol |
|
631 | (12) |
|
|
|
|
631 | (1) |
|
|
632 | (2) |
|
Resveratrol Kinetics in Animals |
|
|
634 | (4) |
|
Resveratrol Kinetics in Humans: Are Data from Animal Models Predictive? |
|
|
638 | (1) |
|
Resveratrol Bioavailability and Biological Effects |
|
|
639 | (2) |
|
|
641 | (2) |
Index |
|
643 | |